Drugs / Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine
Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00365716 | May 2000 → May 2004 | female reproductive system disorder, human papilloma virus infection | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00365716 ↗ |
| Modality | Vaccine | “L1 Virus-Like Particle (VLP) vaccine” NCT00365716 ↗ |